Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma
| GO Term | Evidence Code | Reference |
|---|---|---|
| phosphatidylinositol biosynthetic process | ||
| phagocytosis | ||
| synaptic vesicle exocytosis | ||
| actin cytoskeleton organization | ||
| neutrophil chemotaxis |
| GO Term | Evidence Code | Reference |
|---|---|---|
| ATP binding |
|
|
| 1-phosphatidylinositol-4-phosphate 5-kinase activity | ||
| 1-phosphatidylinositol-4-phosphate 5-kinase activity | ||
| 1-phosphatidylinositol-4-phosphate 5-kinase activity | ||
| phosphatidylinositol kinase activity |
| Position | Description | PubMed ID | GlyTouCan ID | Source |
|---|---|---|---|---|
| 472 |
|
|
| Pathway Name | Organism |
|---|---|
| Clathrin-mediated endocytosis | Homo sapiens |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | Homo sapiens |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | Homo sapiens |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | Homo sapiens |
| Synthesis of PIPs at the plasma membrane | Homo sapiens |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0060653 | lethal congenital contracture syndrome 3 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026